Latest News

  Arnold Levin, Plaintiffs' Lead Counsel in the Chinese Drywall Litigation, announces $800 Million settlement with KPT --View Settlement Notice  --View Press Release
  ABC News Nightline investigates the dangers of Yaz --Watch video
  Levin Fishbein spearheads $53 Million settlement with Banner Supply and its insurers in Chinese Drywall Litigation --Read Press Release  --View Settlement
  FDA 'remains concerned' about blood-clot risk with certain birth-control pills, including Yaz and Yasmin --Read Story  --View FDA Announcement --View Press Release
  Johnson & Johnson cuts maximum Tylenol dose to prevent overdoses --Read story
  Levin, Fishbein, Sedran & Berman investigating bladder cancer claims related to Actos --Read Press Release
  Levin Fishbein reaches settlement with ExxonMobil Corporation, Texaco, Inc., Star Enterprise, Motiva Enterprise, LLC and Spark Electric Services, Inc. in Joseph Meneghin, et al v. ExxonMobil, et al. --View Details
  FDA Places New Warning Label on Zocor: High doses of cholesterol-lowering statin may raise risk of muscle damage, should not be given to new patients, agency says --Read story --View FDA Safety Announcement
  Arnold Levin, Lead Counsel, Negotiates $8 Million Settlement in Chinese Drywall Litigation --Read Story
  Levin, Fishbein, Sedran & Berman and Co-Counsel file suit against Aaron's Inc. over computer spyware allegations --Read Press Release  --View Complaint
  Levin, Fishbein, Sedran & Berman participates in Injunction Proceedings against Aspenway and DesignerWare in Aaron's lawsuit --Read Story
  Drug Information Update - Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone --Read Story
  Two new studies in the British Medical Journal find that Bayer's YAZ and Yasmin birth control pills have an increased risk of blood clot --Read Press Release
  Levin, Fishbein, Sedran & Berman is investigating claims associated with the pain reliever acetaminophen --also known as Tylenol. Tylenol has been linked with severe liver damage, liver failure, and death.
  Levin, Fishbein, Sedran & Berman is investigating claims associated with DePuy ASR Hip Replacements, which have been recalled due to unusually high failure rates.